查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1327823

感染監測解決方案的全球市場

Infection Surveillance Solutions
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 254 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球感染監測解決方案市場將達到 19 億美元

隨著COVID-19之後商業環境的變化，全球感染監測解決方案市場預計2022年為5.749億美元，到2030年將達到19億美元，2022年至2030年的複合年成長率為16。預計還會成長為 4%。軟體是本報告分析的細分市場之一，預計複合年成長率為 15.8%，到分析期結束時將達到 12 億美元。考慮到疫情后持續的復甦，未來八年服務業的複合年複合成長率被修正為17.5%。

美國市場預計將成長2.033億美元，中國複合年成長率為17.5%

到 2022 年，美國感染監測解決方案市場預計將達到 2.033 億美元。中國作為世界第二大經濟體，預計2022年至2030年復合年成長率為17.5%，到2030年市場規模將達到2.338億美元。其他值得注意的地域市場包括日本和加拿大，預計 2022 年至 2030 年將分別成長 14.3% 和 16.2%。在歐洲，德國的年複合成長率預計約為 16.9%。

受訪企業示例

  • IBM Corporation
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Illumina, Inc.
  • Cerner Corporation
  • Ecolab, Inc.
  • Gojo Industries, Inc.
  • Epic Systems Corporation
  • CenTrak, Inc.
  • Iatric Systems, Inc.
  • Harris Healthcare
  • Perahealth, Inc.
  • ABILITY Network Inc.
  • Asolva, Inc.
  • ICNet International

目錄

第1章 調查方法

第2章 執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 競爭

簡介目錄
Product Code: MCP12705

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Infection Surveillance Solutions Market to Reach $1.9 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Infection Surveillance Solutions estimated at US$574.9 Million in the year 2022, is projected to reach a revised size of US$1.9 Billion by 2030, growing at aCAGR of 16.4% over the period 2022-2030. Software, one of the segments analyzed in the report, is projected to record 15.8% CAGR and reach US$1.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Services segment is readjusted to a revised 17.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $203.3 Million, While China is Forecast to Grow at 17.5% CAGR

The Infection Surveillance Solutions market in the U.S. is estimated at US$203.3 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$233.8 Million by the year 2030 trailing a CAGR of 17.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.3% and 16.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 16.9% CAGR.

Select Competitors (Total 40 Featured) -

  • IBM Corporation
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Illumina, Inc.
  • Cerner Corporation
  • Ecolab, Inc.
  • Gojo Industries, Inc.
  • Epic Systems Corporation
  • CenTrak, Inc.
  • Iatric Systems, Inc.
  • Harris Healthcare
  • Perahealth, Inc.
  • ABILITY Network Inc.
  • Asolva, Inc.
  • ICNet International

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • A Prelude to Infection Surveillance Solutions
    • Impact of Covid-19 and a Looming Global Recession
    • The Never-Ending "Race" Between the Virus & Vaccines Continues. Amidst this Chaotic Battle, Where is the World Economy Heading Now & Beyond?
    • Omicron Spreads Panic Worldwide; Omicron Variant Brings Back Memories & Fears of the Worst Part of the 2020 Pandemic
    • South Africa: Omicron's Origin Location
    • Omicron: Impact on Travel Industry
    • Countries that have Already Detected Omicron Cases
    • Steps taken by the Countries to Prevent Transmission of Omicron Variant
    • Fears of Tourism Industry
    • Industry Response to the Travel Curbs
    • Financial Impact
    • Scientists Seek to Gather More Information on Omicron
    • Pharma Firms Aim to Improve Existing Vaccines to Counter Omicron
    • With IMF Making an Upward Revision of Global GDP for 2021, Companies Are Bullish About an Economic Comeback Despite a Continuing Pandemic
    • A Strong Yet Exceedingly Patchy & Uncertain Recovery Shaped by New Variants Comes Into Play: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • COVID-19 Impact On Infection Surveillance Solutions Market
    • Influencer Market Insights
    • World Market Trajectories
    • Infection Surveillance Solutions - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Global Market Analysis and Prospects
    • Infection Surveillance Solutions Market Witnesses Steady Growth
    • Surveillance Software Holds a Significant Share
    • By Infection Type, UTI Holds a Strong Place
    • Hospitals Account for a Major Share of the Market
    • North America and Europe Hold Major Presence, Asia-Pacific to Witness Fastest Growth
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Infectious Diseases Spurs Demand for Infection Surveillance Solutions
    • Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
    • Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
    • Rising Incidence of Hospital Acquired Infections (HAIs) Drives Market Growth
    • Mitigating the Risks Associated With Hospital-Acquired Infections
    • Shift to proactive From Reactive
    • Initiatives for Stewardship
    • Report Production
    • Government Measures to Control HAIs Drive Infection Surveillance Solutions Market
    • Rising Prevalence of Respiratory Infections to Drive Need for POC Molecular Diagnostics
    • Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
    • Infection Control Software Witnesses Steady Growth
    • Advantages of Infection Control Software
    • Clinical Surveillance Innovation to Spur the Infection Surveillance Solutions Market
    • Rising Need to Reduce Healthcare Costs to Propel Demand for Infection Surveillance Solutions
    • Current & Required Healthcare Spending as % of GDP
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Rapidly Aging World Population & COVID-19 Induced Re-Focus on Aging-In-Place to Drive Demand
    • Aging Population Steps-Up The Burden on Healthcare: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Digitalization of Healthcare and Technological Advancements
    • Digital Health Investments Record Strong Growth in 2020 1H
    • Digital Health Funding (in US$ billion): 2015-1H2020
    • Increasing Complexity of Healthcare Operations to Spur Demand for Infection Surveillance Solutions Market
    • Global Healthcare IT Market (2020): Percentage Breakdown of Spending by Sector
    • The Move to Cloud Gains Momentum
    • Rise in Pollution Levels Trigger Increase in Respiratory Diseases, Driving Market Opportunities
    • Percentage Share Breakdown of Global Deaths Linked to Air Pollution
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Infection Surveillance Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Infection Surveillance Solutions by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Long-Term Care Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Long-Term Care Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Long-Term Care Facilities by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Infection Surveillance Solutions Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • Active Players in United States
    • TABLE 20: USA Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2023 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2023 & 2030
  • CANADA
    • Active Players in Canada
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2023 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2023 & 2030
  • JAPAN
    • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • Active Players in Japan
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2023 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2023 & 2030
  • CHINA
    • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • Active Players in China
    • TABLE 38: China Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: China 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2023 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: China 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2023 & 2030
  • EUROPE
    • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Infection Surveillance Solutions by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Infection Surveillance Solutions by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2023 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2023 & 2030
  • FRANCE
    • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • Active Players in France
    • TABLE 53: France Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: France 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2023 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: France 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2023 & 2030
  • GERMANY
    • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • Active Players in Germany
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2023 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2023 & 2030
  • ITALY
    • Active Players in Italy
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2023 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • Active Players in United Kingdom
    • TABLE 71: UK Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2023 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • Active Players in Rest of Europe
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2023 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • Active Players in Asia-Pacific
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2023 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • Active Players in Rest of World
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2014, 2023 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2014, 2023 & 2030

IV. COMPETITION